Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee

Chiara Baldini, MD, PhD

University of Pisa
Pisa, Pisa, Italy

MD

Presentation(s):

  • 1380: Phenotyping Neuropathic Pain in Sjögren’s Disease: A Cluster-Based Approach

    Monday, October 27, 2025
    10:30 AM - 12:30 PM Central Time

    Disclosure(s): aurina: Advisor or Review Panel Member (Terminated); GlaxoSmithKlein(GSK): Consultant (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Horizon AMGEN: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); johnson and johnson: Advisor or Review Panel Member (Terminated, September 28, 2025); Novartis: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); sanofi: Consultant (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)

  • 1381: Self-Reported and Actigraphic Sleep and Circadian Rhythm Disruptions in Patients with Sjögren’s Disease: Associations with Disease Activity and Patient-Reported Outcomes

    Monday, October 27, 2025
    10:30 AM - 12:30 PM Central Time

    Disclosure(s): aurina: Advisor or Review Panel Member (Terminated); GlaxoSmithKlein(GSK): Consultant (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Horizon AMGEN: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); johnson and johnson: Advisor or Review Panel Member (Terminated, September 28, 2025); Novartis: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); sanofi: Consultant (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)

  • 27M33: Abstracts: Sjögren’s Disease – Basic & Clinical Science

    Monday, October 27, 2025
    1:00 PM - 2:30 PM Central Time

    Disclosure(s): aurina: Advisor or Review Panel Member (Terminated); GlaxoSmithKlein(GSK): Consultant (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Horizon AMGEN: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); johnson and johnson: Advisor or Review Panel Member (Terminated, September 28, 2025); Novartis: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); sanofi: Consultant (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)